Drug Shortage Report for MINT-PIOGLITAZONE

Last updated on 2020-04-25 History
Report ID 95924
Drug Identification Number 02326485
Brand name MINT-PIOGLITAZONE
Common or Proper name Pioglitazone
Company Name MINT PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) PIOGLITAZONE
Strength(s) 30MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 count bottles
ATC code A10BG
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-10-09
Estimated end date 2020-06-30
Actual end date
Shortage status Actual shortage
Updated date 2020-04-25
Company comments
Health Canada comments
Contact Address 6575 DAVAND DRIVE
MISSISSAUGA, ONTARIO
CANADA L5T 2M3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2020-04-25 French Compare
v8 2020-04-25 English Compare
v7 2020-04-09 French Compare
v6 2020-04-09 English Compare
v5 2020-01-27 French Compare
v4 2020-01-27 English Compare
v3 2019-10-10 English Compare
v2 2019-10-09 French Compare
v1 2019-10-09 English Compare